logo
Workers at Mowi salmon processor 'treated worse than fish'

Workers at Mowi salmon processor 'treated worse than fish'

BFAWU General Secretary Sarah Woolley said: "Every worker going to work should feel that their health, safety and well-being is sacrosanct and a central priority of their employer. But, in our time representing workers at Mowi we have found that our members at Mowi are not treated with the respect and the dignity that every worker deserves.
'This report outlines many of the issues we have concerns about, based on the work we have done with members and speaking directly with them about their observations and experiences. We truly hope that our report acts as a wake up call to management at the plant.'
The report, based on testimony of workers and union officials who represent employees at Mowi, revealed a long list of complaints including 'lack of toilets, time limited toilet breaks, workers having to get toilet cover before they go, inadequate canteen facilities including a lack of seating for workers often working 12 hour shifts.'
Other concerns included 'lack of mitigation to help workers working in cold working temperatures for long periods of time and manual handling practices that could be resulting in injuries from repetitive work are some of the concerns raised in the report.
Strong concerns were also expressed about their sickness absence policy, deemed 'unfair because it gives discretion to managers about whether a worker gets sick pay or not if they are off sick'.
In some cases staff spoke of having had sick pay withdrawn even if they are off work due to workplace accidents and injuries.
READ MORE:
These issues raised in the report have led the bakers' union to 'question just how seriously Mowi takes the 'human rights' of its workers'.
In their 2021 annual report Mowi wrote about the importance of human rights and how it is at the core of their operations. 'Human rights are at the core of a sustainable business.'
BFAWU Scottish organiser Mark McHugh said: "Through the work we do representing workers and from talking to members it seems that too often the health and well-being, physical and mental, is a secondary consideration for the management of Mowi at Rosyth. At times it feels like the 'workers are treated worse than the fish'.
'This is contrary to their self congratulatory proclamations about how much they respect human rights. We are concerned that basic rights are not applied at their Rosyth plant. No adult should be told when to go to the toilet, if they can go and how long they can go for. It is ridiculous and wrong but sadly this is the culture that this report has exposed.'
(Image: Oxana Kolodina on Unsplash)
'If there was a functioning and proactive health and safety culture then many of the issues we have raised in the report would have been dealt with, the fact they haven't been demonstrates how unsatisfactory their approach is.'
An intervention in writing to the company during the writing of the report has resulted in some small improvements.
McHugh said: 'We have always said to Mowi that as a union we want to engage constructively with them to help make improvements to the terms and conditions of workers at Mowi in Rosyth.
'We believe this will benefit the workforce and indeed the company as a whole. We are as always ready to speak to the company and work with them to improve health and safety at Rosyth. We hope that they do so."
A spokesperson for Mowi said: "At Mowi, we take ethical employment, including the safety and wellbeing of our workforce, extremely seriously. We undergo regular unannounced audits by independent third parties to verify this. As such, we do take issue with the points raised by the BFAWU which are false and misleading.
"Mowi operates standard procedures in a processing plant. With regard to toilet breaks, there is no truth at all in the allegation that these are timed or limited to seven minutes. We do require an allocated number of people working on a line at any given time to keep it running. This is the same for any factory running a production line.
"Our compliance and practices are under constant review, checked internally and through regular independent external third-party audits. We have robust safety management practices in place. All roles and activities are risk-assessed by both qualified Health and Safety professionals and Occupational Health experts, and all advice provided by them is implemented. In addition, employees are actively encouraged to raise ideas, suggestions or concerns.
"We also have a Health and Safety Committee which meets each month and is represented by Safety Reps, adhering to the Health and Safety (Consultation with Employee) Regulations of 1996.
"On a practical level, just as one of many examples, we have invested several millions of pounds into new equipment which reduces the number of repetitive tasks carried out on site - choosing to engineer out risk rather than simply reducing it by asking employees to rotate between tasks.
"With regard to sickness benefit, we go further than statutory sick pay with an enhanced Company Sick Pay (CSP) policy. CSP is paid consistently, subject to the individual in question having met our sickness absence rules, which include keeping Mowi informed about the nature and expected duration of the absence. This is standard practice.
"Finally, with regard to wages, making simple pay comparisons to other countries ignores complex differences in cost of living, income tax rates and state benefits. Our reward structure is transparent and fair.
"Mowi is supportive of our colleagues' rights to join a union and to seek collective representation, should they wish."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

I shed 6st on Mounjaro – the common mistake that can hinder weight loss & 3 foods you need to eat from the start
I shed 6st on Mounjaro – the common mistake that can hinder weight loss & 3 foods you need to eat from the start

Scottish Sun

time8 hours ago

  • Scottish Sun

I shed 6st on Mounjaro – the common mistake that can hinder weight loss & 3 foods you need to eat from the start

WEIGHT TO GO I shed 6st on Mounjaro – the common mistake that can hinder weight loss & 3 foods you need to eat from the start Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A MUM who slimmed down five dress sizes thanks to Mounjaro has shared her top tips for those wanting to shed weight with fat jabs. Katie McCutcheon, from Glasgow, Scotland, who lost over 5st in just nine months, said one of these tips was critical to remaining motivated while on Mounjaro. Sign up for Scottish Sun newsletter Sign up 4 The Scottish mum said her biggest hint was for people on the drug to not fixate on a number on scale Credit: TIKTOK/@ 4 Two of her other tips were to consume a diet high in protein and have healthy snacks Credit: TIKTOK/@ 4 Mounjaro is typically used to treat type 2 diabetes Credit: Getty Mounjaro, which is known as the King Kong of jabs, is now being prescribed on the NHS in the first anti-obesity rollout of its kind. It is said to suppress the ­appetite, making people feel fuller for longer. Such injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese - with a Body Mass Index of 30 or over. One jab is administered each week but the duration is dependent on a person's weight. Sharing her tips in a TikTok clip, the Scottish mum said her biggest hint was for people on the drug to not fixate on a number on scale. ''If you are hyper-focused on a number on a scale you're probably going to be so obsessed with it that you won't be able to celebrate your non scale victories,'' she advised. ''Like going down a clothing size, or two, or three, or your health being so much better.'' The mother of-two explained that doing so will help you avoid a pitfall that can kill your motivation to stick with the drug, as well as dieting. ''It will be disheartening if you are comparing yourself to other people because it's your journey at the end of the day and no one else's,'' she said. Another of her top tips to help others shed the weight was to ensure they're hydrated and drink plenty of water. I went on fat jabs but the hair loss was unbelievable so I quit - I'd rather be chubby with hair than skinny and bald ''Drink your three to four litres of water a day, if you don't you're probably going to see probably not going to lose (weight) as quickly,'' she said. Two of her other tips were to consume a diet high in protein and have healthy snacks dotted around the house and available when you're on the go. The mum, who posts under the username @ said she currently eats about 60g of protein per day, the equivalent of about two chicken breasts. However, Katie also warned that people following a high protein diet needed to be aware of the potential consequences. ''Please be aware that having a high protein diet you could end up with a side effect like constipation because you're not putting any fibre into your diet, so you need to supplement that in some way,'' she said. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. The ''plus-size content creator'' also said she advised people to have high protein and low-calorie snacks dotted around to deal with hunger cravings. ''One minute I will be like, 'No, I can't eat a single thing, I am not hungry in any way shape or form,' and then the hunger comes back like that in an instant'', she said. The mother said protein shakes and chicken satay skewers were good options to have on the go. In her video, Katie explained that by planning snacks Mounjaro patients could ensure they were sticking to their diet and not go for more calorific options that could slow down the weight loss process. ''If you don't have something to satiate that hunger you might then end up snacking and you might not count for calories and you could go over your daily calorie deficit,'' she warned. ''We all know that with this medication you need to be in a calorie deficit to lose weight so keep some nice snacks dotted about.'' What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin. In the comments, the stunner explained she was on a 1,300 calorie deficit diet, where you consume fewer calories than you use in a day, forcing the body to burn its fat reserves. A 1,300 calorie deficit is 100 less than the NHS's recommended 1,400 for women on such diets. Women are typically advised to only consume a maximum of 2,000 calories per day by the health service. Katie's final tip for people on the drug was to maintain healthy habits, such as calorie counting and staying hydrated, while using the medication. ''If you let those habits drop, like I've done two or three times during this journey, you're probably going to notice stalls,'' she said. ''It's because you're not as focused on calorie counting any more. ''You might have a bad week or a bad couple of weeks, but that does not derail this journey.'' 4 Be aware of the dangers While hailed as revolutionary for the fight against obesity GLP-1 medications, like any drug, do come with the risk of side effects, some potentially deadly. Experts and NHS medics have shared a stern warning about the dangers of taking such medications without a prescription. Following the death of a man from Burton upon Trent, Staffs, who died after taking Mounjaro, his family are now calling for a probe into the jab's "potential to kill."

‘We are all Sandy Peggie' banners, a press scrum and an unprecedented case
‘We are all Sandy Peggie' banners, a press scrum and an unprecedented case

Scotsman

time10 hours ago

  • Scotsman

‘We are all Sandy Peggie' banners, a press scrum and an unprecedented case

Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... It is one of around 40,000 employment tribunals dealt with each year by the HM Court & Tribunals Service, but few, if any, have generated such interest and debate. Even before the tribunal brought by Sandie Peggie resumed taking evidence yesterday after a five-month break, the level of scrutiny and attention was clear to see. Advertisement Hide Ad Advertisement Hide Ad Outside the offices in Dundee's Greenmarket, a large contingent of press photographers and broadcasters were in attendance alongside supporters of Ms Peggie holding banners. 'We are all Sandy Peggie', read one. READ MORE: Sandie Peggie cleared of misconduct charge Such was the level of demand for access to the hearing's live stream, interested parties were asked to log on a half hour before it began, with numerous tests to ensure everyone could hear, and see, the proceedings. Isla Bumba, NHS Fife Equality & Human Rights Lead Officer, arrives with Jane Russell KC who is representing NHS Fife at the Sandie Peggie tribunal (Picture: Lisa Ferguson) | TSPL When the hearing eventually started, the online lobbies were full, comprising not just a small army of journalists from the Scottish and UK media, but numerous members of gender critical campaign groups and prominent commentators on such issues. The day's proceedings were largely overshadowed by the events of the previous evening, when it emerged that Ms Peggie had been cleared of four gross misconduct allegations by NHS Fife, but the evidence that was heard on Wednesday remained significant. Advertisement Hide Ad Advertisement Hide Ad Over the course of around five hours, there was intense scrutiny of the health board's policies - or lack of them - and the decisions that were taken in allowing Dr Beth Upton, a trans woman, to use female facilities. Only one person - Isla Bumba, lead officer for equality and human rights at NHS Fife - gave evidence, but plenty of details emerged to generate discussion in the case, especially when Ms Bumba was questioned by Ms Peggie's lawyer, Naomi Cunningham. Ms Bumba explained that the advice she gave at the time was that not letting a trans person use the space that aligned with their gender 'could be deemed discriminatory,' and over the course of numerous questions and answers, she and Ms Cunningham addressed at length the kind of issues that have been major talking points before and since April's landmark Supreme Court gender ruling. Supporters of Sandie Peggie outside the tribunal. Picture: Lisa Ferguson | Lisa Ferguson Ms Cunningham asked her about the definition of 'trans', and suggested that Dr Upton was a man who wants to be seen and treated as a woman, to which Ms Bumba replied: 'I think that's your definition, I would say that Beth is a trans woman.' Advertisement Hide Ad Advertisement Hide Ad Elsewhere, Ms Bumba said that she would 'reach out to HR' when presented with the hypothetical scenario of being approached by a woman and a trans person complaining about who is able to use changing facilities. Ms Cunningham, however, accused her of 'ducking' the question. There was also ambiguity when Ms Bumba was asked if a 'third space' could have been provided for trans members of staff to get changed. She said that was a 'complicated question' and that she was not sure she could comment.

Edinburgh firm beats forecasts after snubbing US approach
Edinburgh firm beats forecasts after snubbing US approach

The Herald Scotland

time11 hours ago

  • The Herald Scotland

Edinburgh firm beats forecasts after snubbing US approach

The update could be seen as vindication of the company's decision to resist the approach from Bain, which it said 'fundamentally' undervalued Craneware and its prospects and focus on a strategy that it argued would 'create significant value for shareholders'. Craneware's software is used in about 2,000 hospitals across the US, giving it an approximately 40% share of that market. Its products are used by around a further 10,000 clinics and affiliate retail pharmacies. The company told the market today that it 'experienced positive trading throughout the fiscal year, delivering continued strong growth, and profitability ahead of consensus market expectations'. Annual recurring revenue increased by 7% to $184 million amid 'continued sales momentum' and the company stated that it continued to 'deliver high levels of operating cash conversion, which have been used to invest in the product portfolio, reduce debt, and interest costs'. Total bank debt was reduced to $27.7m from $35.4m, while cash reserves stood at $55.9m by year-end, up from $34.6m last year. Scots firms 'still on a knife-edge' despite fall in administrations Former Rangers chief bidding to 'reset' renowned Scottish retailer 'We believe in Glasgow': Developer gives city huge vote of confidence And the company underlined its confidence of achieving further growth, declaring that it 'anticipates that the ongoing drive within US healthcare to improve efficiency and deliver value in healthcare will continue to provide a positive market environment for Craneware's offerings'. Craneware added: 'The partnership with Microsoft is progressing well, raising the profile of The Craneware Group and its AI-powered Trisus offerings with hospital CIOs (chief information officers) across the US, providing the basis for increased market penetration in future periods. AI development in conjunction with Microsoft continues as planned.' Chief executive Keith Neilson said in a statement to the stock market: 'We are pleased to see our growth rates accelerating and profitability exceed expectations, with this year's performance supporting a move to sustainable, double-digit growth. 'Our extensive data sets and the powerful insights we can provide via our Trisus platform give our customers the means they need to improve their operational and financial performance. We have a unique capability to support our customers in their missions, and are seeing this translate into continued strong expansion sales within our customer base and a significant and growing base of recurring SaaS (software as a service) revenues. 'With continued strong cash generation, and a strategic position as a source of independent data and insights at the heart of the US healthcare market, we are excited by the opportunity ahead, for us and our customers, and look to the future with confidence.' Headquartered in Edinburgh, Craneware has about 200 employees in the UK made up mainly of product developers and engineers. The company employs roughly another 600 people in the US following the £283m acquisition of Florida-based Sentry in 2021. Shares in the company closed up 10.44%, or 235p, at 2,480p.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store